Cargando…

Hepatic arterial infusion but not systemic application of cetuximab in combination with oxaliplatin significantly reduces growth of CC531 colorectal rat liver metastases

PURPOSE: Systemic chemotherapy still represents the gold standard in the treatment of irresectable colorectal liver metastases. Modern anticancer agents like the monoclonal antibody cetuximab have improved the outcome of patients in clinical studies. As hepatic arterial infusion (HAI) is capable to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sperling, Jens, Schäfer, Thilo, Benz-Weißer, Anna, Ziemann, Christian, Scheuer, Claudia, Kollmar, Otto, Schilling, Martin K., Menger, Michael D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639362/ https://www.ncbi.nlm.nih.gov/pubmed/23242249 http://dx.doi.org/10.1007/s00384-012-1617-1

Ejemplares similares

Liver-directed chemotherapy of cetuximab and bevacizumab in combination with oxaliplatin is more effective to inhibit tumor growth of CC531 colorectal rat liver metastases than systemic chemotherapy
por: Sperling, Jens, et al.
Publicado: (2012)

Multidrug Resistance in Rat Colon Carcinoma Cell Lines CC531, CC531(mdr+) and CC531(rev)
por: Gheuens, Eric, et al.
Publicado: (1993)

Characterization of CC-531 as a Rat Model of Colorectal Liver Metastases
por: White, Sarah Beth, et al.
Publicado: (2016)

Intra-arterial EmboCept S® and DC Bead® effectively inhibit tumor growth of colorectal rat liver metastases
por: Ziemann, Christian, et al.
Publicado: (2019)

Intraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma.
por: Veenhuizen, R. B., et al.
Publicado: (1996)

Bone Marrow Suppression by c-Kit Blockade Enhances Tumor Growth of Colorectal Metastases through the Action of Stromal Cell-Derived Factor-1
por: Rupertus, Kathrin, et al.
Publicado: (2012)

Cytotoxic reactions of CC531s towards liver sinusoidal endothelial cells: a microscopical study
por: Vekemans, Katrien, et al.
Publicado: (2004)

Intrahepatic cholangiocarcinoma in a transplant liver - selective internal radiation therapy followed by right hemihepatectomy: report of a case
por: Sperling, Jens, et al.
Publicado: (2014)

Partial hepatectomy enhances the growth of CC531 rat colorectal cancer cells both in vitro and in vivo
por: Herrero de la Parte, Borja, et al.
Publicado: (2021)

Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial
por: Garufi, C, et al.
Publicado: (2010)

Portal Hyperperfusion after Extended Hepatectomy Does Not Induce a Hepatic Arterial Buffer Response (HABR) but Impairs Mitochondrial Redox State and Hepatocellular Oxygenation
por: Dold, Stefan, et al.
Publicado: (2015)

Allergic/infusion reactions reported with cetuximab and rituximab
por: Wolf, Ray A, et al.
Publicado: (2015)

Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin
por: Narvi, Elli, et al.
Publicado: (2018)

Role of Reactive Oxygen Species in the Abrogation of Oxaliplatin Activity by Cetuximab in Colorectal Cancer
por: Santoro, Valeria, et al.
Publicado: (2015)

A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases
por: Feng, Ai-Wei, et al.
Publicado: (2022)

Energy Dept. gives collider 531M of dollars
Publicado: (1997)

531M de dollars pour le LHC
Publicado: (1997)

THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair Inhibitors
por: Shyamsunder, Pavithra, et al.
Publicado: (2022)

Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation
por: Balin-Gauthier, D, et al.
Publicado: (2008)

Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience
por: Adams, R A, et al.
Publicado: (2009)

Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer
por: Zhang, Zhan-Dong, et al.
Publicado: (2014)

High incidence of cetuximab-related infusion reactions in head and neck patients
por: Palomar Coloma, Virginia, et al.
Publicado: (2018)

Management of infusion reactions associated with cetuximab treatment: A case report
por: Ohshita, Naohiro, et al.
Publicado: (2017)

531. Reducing Inappropriate Hospital-Acquired Clostridium difficile Diagnoses
por: Duncan, Robert, et al.
Publicado: (2018)

SUN-531 Screening for Coexisting Diseases in Patients with Fibrous Dysplasia
por: Huma, Zilla, et al.
Publicado: (2019)

Origin and Diversification of Land Plant CC-Type Glutaredoxins
por: Ziemann, M., et al.
Publicado: (2009)

Hemolytic uremic syndrome following the infusion of oxaliplatin: case report
por: Dahabreh, Issa, et al.
Publicado: (2006)

Clinical and economic impact of infusion reactions in patients with colorectal cancer treated with cetuximab
por: Foley, K. A., et al.
Publicado: (2010)

Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228)
por: Lévi, Francis, et al.
Publicado: (2017)

A Phase II Study of Cetuximab (Erbitux®) plus FOLFIRI for Irinotecan and Oxaliplatin-refractory Metastatic Colorectal Cancer
por: Koo, Dong Hoe, et al.
Publicado: (2007)

Combination Chemotherapy of Azacitidine and Cetuximab for Therapy-Related Acute Myeloid Leukemia following Oxaliplatin for Metastatic Colorectal Cancer
por: Hashimoto, Akari, et al.
Publicado: (2014)

ARQ531: the therapy that targets multiple pathways in acute myeloid leukemia
por: Hellmich, Charlotte, et al.
Publicado: (2020)

531 Utilization of a Nurse Care Coordinator to Streamline the Outpatient Experience
por: Neal, Joya, et al.
Publicado: (2023)

Hepatic Arterial Infusion Oxaliplatin Plus Oral S-1 Chemotherapy in Gastric Cancer with Unresectable Liver Metastases: A Case Series and Literature Review
por: Wang, Kangxin, et al.
Publicado: (2020)

Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer
por: Klinghammer, Konrad, et al.
Publicado: (2020)

Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study
por: Kullmann, F, et al.
Publicado: (2009)

Optimal timing for antimicrobial prophylaxis to reduce surgical site infections: a retrospective analysis of 531 patients
por: Paasch, Christoph, et al.
Publicado: (2023)

Study of 531 consecutive cases of severe head trauma in Florianópolis, 1994-2000
por: Martins, ET, et al.
Publicado: (2001)

Lytic and Chemotactic Features of the Plaque-Forming Bacterium KD531 on Phaeodactylum tricornutum
por: Chen, Zhangran, et al.
Publicado: (2017)

Study on the Effect of Ultraviolet Absorber UV-531 on the Performance of SBS-Modified Asphalt
por: Liu, Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gu29o82too8qsn82s733en8nts